Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/11/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Cristina Csimma

Wrong Dr. Cristina Csimma?

Chief Executive Officer

Cydan Development Inc
300 Technology Square, 8th Floor
Cambridge , Massachusetts 02139
United States

Company Description: Cydan focuses on identifying promising assets with well-understood biology and proof-of-concept data in in vivo models from academia, industry and other sources....   more
Background

Employment History

Board Memberships and Affiliations

Education

  • PharmD
  • Bachelor of Science
21 Total References
Web References
MDA Venture Philanthropy - Management - Committees
www.mdavp.org, 5 Nov 2014 [cached]
Cristina Csimma, PharmD, M.H.P. Founder and Chief Executive Officer Cydan Development, Inc
...
Cristina Csimma
Cristina Csimma brings extensive drug development experience in the biopharmaceutical, venture capital and academic settings. Prior to joining Cydan, Dr. Csimma worked in advisory roles with biopharmaceutical and venture capital firms, was Vice President, Drug Development at Virdante Pharmaceuticals Inc. and was a principal at Clarus Ventures LLC, a leading life sciences venture capital firm. Previously, she held roles in CR&D and Translational Research at Wyeth Research and the Genetics Institute. Her global drug development experience encompasses multiple therapeutic areas including neuromuscular disease, exploratory through registration clinical studies, and integration of biomarkers and novel technologies into clinical development. Before joining the biopharmaceutical industry, she was a clinical pharmacist at the Dana-Farber Cancer Institute.
Dr. Csimma serves on the board of directors of Columbia Labs Inc., and is a member of the MDA Venture Philanthropy Scientific Development Advisory Committee; the external oversight board to the NIH NINDS NeuroNext (Network for Excellence in Neuroscience Clinical Trials); the TREAT-NMD Advisory Committee for Therapeutics (TACT) (former chair), the Department of Defense CDMRP Duchenne Muscular Dystrophy Research Program Integration Panel, and Northeastern University's Health Sciences Entrepreneurs program steering committee.
Dr. Csimma received her Bachelor of Science and Doctor of Pharmacy degrees from Massachusetts College of Pharmacy, and a Master of Health Professions from Northeastern University.
CureDuchenne: Scientific Advisory Board
www.cureduchenne.org, 29 Oct 2014 [cached]
Cristina Csimma, PharmD, MHP
Chief Executive Officer,
Cydan Development, Inc.
Cydan Management Team
www.cydanco.com, 11 July 2014 [cached]
Cristina Csimma | Cristina Csimma, PharmD, MHP
...
Cristina Csimma | Cristina Csimma, PharmD, MHP
...
Cristina Csimma Board of Directors
...
Cristina Csimma Board of Directors
...
Cristina Csimma, PharmD, MHP Founder, Director and Advisor
Dr. Csimma was the founding CEO of Cydan. Prior to Cydan she worked in advisory roles with biopharmaceutical and venture capital firms, was Vice President, Drug Development at Virdante Pharmaceuticals Inc. and was a Principal at Clarus Ventures LLC. Previously, she held roles in Clinical Research and Translational Medicine at Wyeth and Genetics Institute. Her global development experience encompasses multiple therapeutic areas including rare diseases, exploratory through registration clinical programs and integration of biomarkers and novel technologies into development. She started her career as a clinical pharmacist at the Dana Farber Cancer Institute.
Dr. Csimma serves on the board of directors of Columbia Labs Inc., and is a member of the MDA's Scientific Development Advisory Committee; the external oversight board to the NIH NINDS NeuroNext (Network for Excellence in Neuroscience Clinical Trials); the TREAT-NMD Advisory Committee for Therapeutics (TACT) (former chair), and Northeastern University's Health Sciences Entrepreneurs program steering committee.
Dr. Csimma received her Bachelor of Science and Doctor of Pharmacy degrees from Massachusetts College of Pharmacy, and a Master of Health Professions from Northeastern University.
Cristina Csimma, PharmD, MHP
About Us – Leadership
www.columbialabs.com, 10 Aug 2014 [cached]
Cristina Csimma, PharmD
Venture Advisor, New Enterprise Associates
"Cydan is taking a new ...
www.nea.com, 11 April 2013 [cached]
"Cydan is taking a new approach to drug development - one that takes advantage of recent scientific breakthroughs in rare diseases and is externally focused, highly collaborative and capital efficient," said Cristina Csimma, Pharm.D., Chief Executive Officer of Cydan.
...
"We look forward to partnering with Cristina and her leadership team as they leverage a capital-efficient approach to identifying and de-risking multiple assets.
...
Dr. Csimma has held development leadership positions at Virdante Pharmaceuticals, Wyeth Research and Genetics Institute, was a Principal at Clarus Ventures and has worked with rare disease non-profit organizations.
Other People with the name "Csimma":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.